Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
| Title: | Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND) |
|---|---|
| Authors: | Shi, Vivian Y., Bhutani, Tina, Fonacier, Luz, Deleuran, Mette, Shumack, Stephen, Valdez, Hernan, Zhang, Fan, Chan, Gary L., Cameron, Michael C., Yin, Natalie C. |
| Source: | In Journal of the American Academy of Dermatology August 2022 87(2):351-358 |
| Database: | ScienceDirect |
| ISSN: | 01909622 |
|---|---|
| DOI: | 10.1016/j.jaad.2022.04.009 |
| Published in: | Journal of the American Academy of Dermatology |
| Language: | English |